Evaluation of detection and characterization of liver tumor with 3D rapid acquisition sequence with compressed sensing

Evaluation of detection and characterization of liver tumor with 3D rapid acquisition sequence with compressed sensing - Efficacy of 3D high speed imaging method with compressed sensing for liver tumors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035896

Enrollment

100

Registered

2019-02-17

Start date

2018-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumor

Interventions

Contrast enhanced MRI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients whose liver tumor was pointed out by CT or ultrasound and examined necessary for MRI. 2. High risk patients with hepatocellular carcinoma with chronic liver disease. 3. Transcatheteric embolization or radiofrequency ablation therapy for hepatocellular carcinoma was performed, and examination was made based on follow-up observation. 4. Patient with colorectal cancer or pancreatic cancer for the purpose of examining metastatic liver cancer. 5. Over 20 years old. 6. Gender does not matter.

Exclusion criteria

Exclusion criteria: 1. Patients with allergic history with bronchial asthma or past nonspecific extracellular fluid contrast agents or hepatocyte specific contrast agents. 2. Patients with impaired renal function. 3. Patients with internal metals. 4. Claustrophobia.

Design outcomes

Primary

Measure	Time frame
Accuracy for detection of hypervascular hepatocellular carcinoma. Accuracy for characterization of enhance,ent pattern of tumor.	—

Countries

Japan

Contacts

Public ContactKazuiro Saito

Tokyo Medical University Radiology

saito-k@tokyo-med.acjp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026